575 — Regent Pacific Share News
0.000.00%
Last trade - 00:00- HK$283.06m
- HK$312.69m
- $0.36m
Brief: Endurance RP Sees Loss Attributable To Equity Holders For Year Of Between Approximately US$11.50 Million To Approximately US$14.00 Million
Brief: Endurance RP Says Agreement For Rights To Commercialise Fortacin In Israeli And Balkan Regions
Brief: Regent Pacific Says Disposed 7.2 Million Vxr Shares For A$5.92 Million
Brief: Regent Pacific Sees Profit Attributable For HY Of Between About US$0.50 MLN - US$4 MLn
Brief: Regent Pacific FY Loss Attributable US$24.4 Mln
Brief: Regent Pacific Group Ltd Sees Loss Attributable For Year Between $21 Million To $25 Million
Brief: Regent Pacific Says Advised That Clinical Trial Approval Obtained Post Review Of SenstendTM
Brief: Regent Pacific Group Expects To Launch Fortacin In Macau In March 2021 & In Taiwan In April 2021
Brief: Regent Pacific Group Says Operations Update On Fortacin
Brief: Regent Pacific Says Acquired All Of Issued And Outstanding Securities In Deep Longevity, Inc
Brief: Regent Pacific Updates On Operations On Fortacin
Brief: Regent Pacific Group Looking Into Options At Scaling Up Manufacturing For Fortacin
Brief: Regent Pacific Group Says To Buy Shares & DLI ESOP Awards In Deep Longevity, Inc
Brief: Regent Pacific Group HY Loss Attributable US$27.2 Mln
Brief: Regent Pacific Says Remains On Target To Complete Phase II Validation Study Of Fortacintm By End Of 2020
Brief: Regent Pacific Group Says FY Loss Attributable US$66.0 Mln
Brief: Regent Pacific Sees Loss Attributable For Year Of Between Us$67 Million To Us$70 Million
Brief: Regent Pacific Group Sees FY Loss Attributable Of Between Us$42 Mln To Us$45 Mln
Brief: Regent Pacific Group Says April Vxr Disposal & Vxr Disposals Generated Aggregate Consideration Of About A$3.05 Mln